INDUS (INH) 16th IIF - International Investment Forum summary
Event summary combining transcript, slides, and related documents.
16th IIF - International Investment Forum summary
8 Oct, 2025Strategy and business model
Focuses on acquiring and developing small and medium-sized engineering companies across three segments: Engineering, Infrastructure, and Materials.
Aims for long-term, sustainable growth with a target of EUR 3 billion in sales by 2030, including EUR 600 million from acquisitions.
Operates as an 'evergreen' financial investor, supporting succession in German Mittelstand companies.
Management board consists mainly of experienced engineers, emphasizing operational expertise.
Active portfolio development includes in-house experts focusing on operational excellence, innovation, and sustainability.
Financial performance and outlook
Generated EUR 1.7 billion in sales and EUR 154 million EBITDA in 2024, with strong free cash flow generation.
Free cash flow was nearly EUR 200 million in 2023 and EUR 135 million in 2024; guidance for 2025 is over EUR 90 million.
H1 2024 sales remained stable despite a weak economy; Q2 outperformed the previous year.
Adjusted EBITDA dropped 24% in H1, but recovery is expected in H2 due to backend-loaded segments.
Maintains leverage between 2 and 2.5x EBITDA, with an equity ratio of 38%.
Strategic initiatives and internationalization
New strategy 'empowering Mittelstand' focuses on internationalization, M&A, and technology.
Plans to invest EUR 500 million in acquisitions by 2030, expanding in Europe and the U.S.
Five add-on acquisitions completed in H1 2024 for EUR 22 million; further deals expected.
Venture clienting program launched to foster collaboration with startups without M&A.
Scandinavian region identified as a continued target area for expansion.
Latest events from INDUS
- Sales and EBIT fell, but EPS and free cash flow rose; guidance lowered amid economic headwinds.INH
Q2 20242 Mar 2026 - Sales stable, margins pressured by tariffs; guidance and strong H2 outlook confirmed.INH
Q2 20252 Mar 2026 - Record Q3 revenue and 10% EBITA growth, with guidance reaffirmed amid economic headwinds.INH
Q3 202512 Nov 2025 - Sales and EBIT fell year-over-year, but Q3 margins and cash flow improved.INH
Q3 202413 Jun 2025 - INDUS pursues ambitious growth to EUR 3 billion sales by 2030 through M&A and innovation.INH
CMD Presentation6 Jun 2025 - Sales and earnings fell, but order intake and equity ratio improved in Q1 2025.INH
Q1 20255 Jun 2025 - 2024 results met guidance, with resilient EBIT, improved equity ratio, and strategic acquisitions.INH
Q4 20245 Jun 2025